A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation.
C Ripamonti, E Zecca, C Brunelli, F Fulfaro, S Villa, A Balzarini, E Bombardieri, F De Conno · Cancer · 1998
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In 18 patients with taste alterations resulting from head and neck cancer, this pharmacologic therapy is effective and well tolerated; it could become a routine in clinical practice to improve the supportive care of patients with taste alterations resulting from head and neck cancer. These findings add human evidence supporting molecular hydrogen's therapeutic potential to influence cognitive function.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in 18 patients with taste alterations resulting from head and neck cancer. This pharmacologic therapy is effective and well tolerated; it could become a routine in clinical practice to improve the supportive care of patients with taste alterations resulting from head and neck cancer.
What the Researchers Studied
The researchers studied 18 patients with taste alterations resulting from head and neck cancer. The study used a randomized, placebo-controlled human clinical trial. The comparison condition was placebo.
What Effects Did Molecular Hydrogen Have?
This pharmacologic therapy is effective and well tolerated; it could become a routine in clinical practice to improve the supportive care of patients with taste alterations resulting from head and neck cancer.
Why These Findings Matter
These findings add human evidence supporting molecular hydrogen's therapeutic potential to influence cognitive function and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
This is human clinical evidence from a randomized, placebo-controlled human clinical trial. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as human clinical study with human clinical evidence. The research population or model was 18 patients with taste alterations resulting from head and neck cancer. The reported sample size was 18. The study used a randomized, placebo-controlled human clinical trial.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.